𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antibody constructs for radioimmunodiagnosis and treatment of human pancreatic cancer

✍ Scribed by Apollina Goel; Surinder K. Batra

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
112 KB
Volume
21
Category
Article
ISSN
0270-3211

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Perspectives of combined radioimmunother
Perspectives of combined radioimmunotherapy and anti-EGFR antibody therapy for the treatment of residual head and neck cancer
✍ Frank B. van Gog; Ruud H. Brakenhoff; Marijke Stigter-van Walsum; Gordon B. Snow πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 119 KB πŸ‘ 1 views

Rhenium-186 based radioimmunotherapy (RIT) may have potential for the treatment of minimal residual disease in patients with squamous cell carcinoma of head and neck (HNSCC). In an effort to enhance the efficacy of RIT, we evaluated the combination of RIT and anti-epidermal growth factor receptor (E

Recombinant antibody toxins specific for
Recombinant antibody toxins specific for ErbB2 and EGF receptor inhibit the in vitro growth of human head and neck cancer cells and cause rapid tumor regression in vivo
✍ Marc Azemar; Mathias Schmidt; Friederike Arlt; Pierre Kennel; Burkhard Brandt; A πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 130 KB πŸ‘ 2 views

## Overexpression of the ErbB2 and epidermal growth factor receptor (EGFR) tyrosine kinases is frequently observed in squamous cell carcinomas of the head and neck, and has been correlated with shorter overall survival. By immunoblot analysis, we have found EGFR and ErbB2 expression in 6 out of 6 e